Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 1b/2 Open-Label Study of Disitamab Vedotin Monotherapy or in Combination with Other Anti-Cancer Therapies in Solid Tumors
Sponsored by Seagen Inc.
Active
$724K Funding
3 People
External
Related Topics
cancer,
immunotherapy,
clinical trial,
monotherapy,
combination therapy
People
Linda Garland
Co-Investigator (COI)
Medicine
﹒Professor
Ruth Ca?amar
(CD)
Cancer Center Division
﹒Research Program Administration Officer III
Lizeth Evangelista
(CD)
Cancer Center Division
﹒Research Compliance Administrator II
